Editor's Note :

close editor's note Editor's Note :

On Monday, the court will release orders from the March 27 conference at 9:30 a.m. There is a possibility of opinions at 10:00 a.m. We will be live-blogging starting at 9:25 a.m. at this link, where you can sign up for an email reminder when the live blog begins.

Takeda Pharmaceutical Co. v. Painters and Allied Trades District Council 82 Health Care Fund

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
19-1069 9th Cir. TBD TBD TBD TBD TBD

Issues: (1) Whether the chain of causation between a manufacturer’s allegedly false or misleading statements or omissions and end payments for prescription drugs is too attenuated to satisfy the Racketeer Influenced and Corrupt Organizations Act’s proximate cause requirement, given that every prescription-drug payment depends on numerous intervening factors, including a doctor’s independent decision to prescribe; (2) whether everyone who pays for a product with an alleged latent risk or defect necessarily suffers injury sufficient to confer Article III standing, even when the product is fully consumed, provides the bargained-for benefits and causes no ill effects.

DateProceedings and Orders (key to color coding)
Feb 26 2020Petition for a writ of certiorari filed. (Response due March 30, 2020)
Mar 02 2020Blanket Consent filed by Petitioners, Takeda Pharmaceutical Company Limited, et al.
Mar 19 2020Motion to extend the time to file a response from March 30, 2020 to April 30, 2020, submitted to The Clerk.
Mar 19 2020Motion to extend the time to file a response is granted and the time is extended to and including April 30, 2020.
Mar 27 2020Amicus brief of Washington Legal Foundation submitted.
Mar 27 2020Amicus brief of National Association of Manufacturers and American Tort Reform Association submitted.
 
Share:
Term Snapshot
At a Glance
Awards